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Abstract
Purpose The ICECAP-A is a simple measure of capa-
bility well-being for use with the adult population. The
descriptive system is made up of five key attributes: Sta-
bility, Attachment, Autonomy, Achievement and Enjoy-
ment. Studies have begun to assess the psychometric
properties of the measure, including the construct and
content validity and feasibility for use. This is the first
study to use longitudinal data to assess the responsiveness
of the measure.
Methods This responsiveness study was completed
alongside a randomised controlled trial comparing three
physiotherapy-led exercise interventions for older adults
with knee pain attributable to osteoarthritis. Anchor-based
methodologies were used to explore the relationship be-
tween change over time in ICECAP-A score (the target
measure) and change over time in another measure (the
anchor). Analyses were completed using the non-value-
weighted and value-weighted ICECAP-A scores. The EQ-
5D-3L was used as a comparator measure to contextualise
change in the ICECAP-A. Effect sizes, standardised re-
sponse means and t tests were used to quantify
responsiveness.
Results Small changes in the ICECAP-A scores were
seen in response to underlying changes in patients’ health-
related quality of life, anxiety and depression. Non-
weighted scores were slightly more responsive than value-
weighted scores. ICECAP-A change was of comparable
size to change in the EQ-5D-3L reference measure.
Conclusion This first analysis of the responsiveness using
longitudinal data provides some positive evidence for the
responsiveness of the ICECAP-A measure. There is a need
for further research in those with low health and capability,
and experiencing larger underlying changes in quality of
life.
Keywords Capability  ICECAP-A  Responsiveness 
Psychometrics
Introduction
The ICEpop CAPability measure for Adults (ICECAP-A)
is a new index measure of well-being with theoretical un-
derpinnings in Sen’s [1–4] work on functioning and ca-
pability. Sen’s [2, 3] capability approach advocates an
assessment of well-being that maintains a focus on what a
person is able to do (capability), rather than what a person
does (functioning). The capability approach encourages a
broad evaluative space, which can include a person’s
ability to achieve their basic requirements, such as living in
good health, and more complex abilities, such as the ability
to achieve things that are important to them, such as ful-
filling social or professional roles [4]. Interest in the ap-
proach in health economics [5, 6], public health [7] and
disability [8, 9] has increased in recent years.
The ICECAP-A was developed by Al-Janabi et al. [10]
as a simple measure of capability well-being for use with
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the adult population. They conducted 36 semi-structured
interviews using a purposively selected sample of the
general population to identify what was important to peo-
ple’s lives and well-being. The analysis identified five key
attributes: Stability, Attachment, Autonomy, Achievement
and Enjoyment. Poor health was found to be a key limiting
factor in a person’s ability to attain these attributes. The
second stage involved 18 semi-structured interviews to
establish appropriate terminology for each of the five at-
tributes identified. The final version of the ICECAP-A is
shown in ‘‘Appendix 1’’. The best–worst scaling method
was used to estimate values for the measure [11].
Assessments of reliability [12], construct validity [13],
content validity [14] and feasibility of use [15] of the
measure have been completed with the general public and
healthcare professionals. Responsiveness refers to the
ability of an instrument to measure important or mean-
ingful change [16] and is an important psychometric
property of a measure [17]. Responsiveness is a key factor
in deciding whether a measure will be appropriate for use
in intervention studies.
The aim of this study is to assess the responsiveness of
the ICECAP-A measure. This is the first study to assess the
responsiveness of the ICECAP, using longitudinal outcome
data from a randomised controlled trial.
Methods
Design, participants and setting
This responsiveness study was completed within the Ben-
efits of Effective Exercise for knee Pain (BEEP) trial, a
primary care, multi-centre, pragmatic randomised con-
trolled trial whose aim was to compare improvement in
pain and function outcomes from three physiotherapy-led
exercise interventions for older adults with knee pain at-
tributable to osteoarthritis [18]. Participants were recruited
through either a general practice record search, a survey of
older adults registered with participating practices, or
screening patient referrals to participating physiotherapy
services for knee pain. The inclusion/exclusion criteria
aimed to select a population that was typical of those seen
in primary care. Participants with serious pathology (in-
flammatory arthritis, malignancy, etc.), with previous hip
or knee replacements on the affected side, on a surgical
waiting list for knee replacement, in a nursing home, un-
able to attend clinic due to mobility issues or those in
whom exercise was contraindicated, were excluded.
Participants were randomised to one of three interven-
tions: usual physiotherapy care, individually tailored ex-
ercise and targeted exercise adherence, and patients were
followed up at 3, 6, 9 and 18 months following
randomisation [18]. The intervention arm that participants
were randomised to was not used in this assessment of the
responsiveness of the ICECAP-A.1 Rather, outcome mea-
sures administered to participants in the trial were used to
form anchors against which the responsiveness of the
ICECAP-A could be assessed. Data from baseline and the
6-month follow-up were used, since 6 months were the
trial’s primary end point.
Anchor selection
This analysis used anchor-based methods to explore the
relationship between change over time in scores in the
ICECAP-A and change over time in another measure (the
anchor) [19]. The objective of an anchor-based analysis is
to assess whether scores on the target measure change in
the expected direction as indicated by changes in the scores
on the anchor measure(s).
In line with recommendations by Revicki [19, 20], an-
chors were chosen based on: (a) the change correlation
between the measures, (b) the cross-sectional correlations
at baseline and follow-up between the measures,
(c) whether the analysis using the anchor would increase
the understanding of how the ICECAP-A measure responds
to change in health and whether this would be of impor-
tance to investigators and researchers. It is recommended
that multiple anchors are used [20].
An exploratory analysis of the correlations between the
change scores of BEEP trial outcome measures was used to
assist the choice of anchors for this analysis2 (‘‘Appendix
2’’). Based on this exploratory analysis, and on other points
detailed above, the EuroQoL 5 Dimension Index (EQ-5D-
3L), the Generalised Anxiety Disorder Assessment (GAD-
7) and the Personal Health Questionnaire Depression Scale
(PHQ-8) were chosen as anchors for this analysis. This was
because the change scores of these anchors showed the
strongest correlations with the ICECAP-A change scores
and because baseline correlations between these anchors
and the ICECAP-A were over 0.5. The use of these mea-
sures also has the benefit of including both physical and
mental health domains. The Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)
sub-scales showed very weak correlation in change scores,
so were not used as anchors in this analysis.
1 Therefore, this paper makes no statement about the effectiveness of
the intervention within this trial.
2 Please note that not all measures included in the BEEP trial were
used in the analysis of ICECAP-A responsiveness reported in this
paper. This exploratory analysis identified measures to be used as
anchors, based on predefined criteria recommended by Revicki.
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Anchor group formation
The EQ-5D-3L is a generic preference-based outcome
measure, which measures health-related quality of life
[21–24]. The descriptive system comprises of Mobility,
Self-Care, Usual Activities, Pain and Discomfort, and
Anxiety and Depression [25], with three response options
in each dimension. It is scored via a preference-weighted
algorithm, which for UK values produce a score between -
0.59 and 1. The EQ-5D-3L has been extensively validated
in numerous clinical settings [26–28]. The GAD-7 and the
PHQ-8 are two short questionnaires that assess anxiety [29]
and depression [30], respectively, which have validity
portfolios [30, 31]. They are frequently used in research
and have recognised values, above which anxiety or de-
pression is indicated. The value range is from 0 to 21 for
the GAD-7 and 0 to 24 for the PHQ-8, with a higher score
indicating more severe anxiety and depression symptoms,
respectively. Previous assessments of the construct validity
of the ICECAP-A have shown that health-related quality of
life and psychological or mental health status are related to
ICECAP-A scores [32]. Therefore, some changes in ICE-
CAP-A measures would be expected in response to chan-
ges in these measures.
Each anchor measure was used to divide the sample
into: (1) those that had worsened between baseline and
6-month follow-up and (2) those that had improved be-
tween baseline and follow-up. Three anchors were used in
this analysis. For the EQ-5D-3L, subgroups were formed
using the minimally important change value of 0.074 [33].
Change groups were formed of participants who had
changed by ?or -0.074. Anchor groups from the GAD-7
and PHQ-8 score were not formed using a minimally im-
portant difference as no value could be found in the ex-
isting literature. A value of equal to or greater than ±2 was
used to define the change groups for the GAD-7 and PHQ-
8, which allowed adequate numbers in each of the change
groups. For each anchor, a ‘‘no change’’ group was formed
using the values between the improved and worsened
groups. The numbers in each of the change groups, the
mean change and change as a percentage of possible
change is shown in Table 1.
Value-weighted and non-weighted analyses
When assessing the responsiveness of a value-weighted
measure, consideration needs to be given independently to
both the descriptive system and the value weighting of the
descriptive system [34]. The ability of the descriptive
system to detect change in a construct is an essential pre-
cursor for the ability of a preference-based measure to
accurately reflect preferences. If the analysis is solely
completed using the preference-weighted scores, a con-
clusion might be made that the measure is not responsive;
when in fact, the descriptive system of the measure is re-
sponsive, but the change is not valued [34].
For each anchor, two analyses are presented: (1) an
analysis of the non-weighted descriptive system of the
ICECAP-A and (2) an analysis of the value tariff scores.
For the non-weighted sum score analysis and value tariff
analysis, change was calculated in groups that improved
and worsened. Non-weighted sum scores were calculated
by summing ICECAP-A item scores, with four indicating
full capability on an item and one indicating no capability
on an item. The value tariff was calculated using the al-
gorithm from Flynn et al. [35]. Change was measured both
as actual change and change as a percentage of possible
change, which was calculated by dividing the actual
change by the range of the ICECAP-A measure and mul-
tiplying it by 100. The range of the measure for the non-
weighted ICECAP-A score was 16 (5–20) and for the value
tariff was 1 (0–1).
Analyses
Two effect size (ES) statistics are reported for the change
groups: a standard ES and the standardised response mean
(SRM). The paired t test was used to test the null hy-
pothesis that there has been no change in the mean re-
sponse between baseline and follow-up.
For the GAD-7 and PHQ-8 analyses, the responsiveness
of the EQ-5D-3L was additionally assessed as a comparator
measure to add context to the ICECAP-A results. The use
of the EQ-5D-3L as a comparator to the ICECAP-A was
not designed to assess which measure performs ‘‘best’’, as
they are measures of two different constructs. Rather it was
designed to increase the understanding of the size of
changes in ICECAP-A scores in the context of another
value (or preference)-based measure.
An assessment of the responsiveness of the individual
ICECAP-A items was completed for each anchor measure
using a response profile (the frequency of respondents
answering each level for each item, at baseline and follow-
up). Change in response profiles between baseline and
follow-up was analysed for each level of each item to
indicate which items were the ‘‘drivers’’ of change in the
overall measure.
A methodological note
The majority of responsiveness analyses of patient-reported
outcome measures seek to assess how the scores of a
measure change when the construct that the measure is
designed to assess changes. This analysis was different and
Qual Life Res (2015) 24:2319–2331 2321
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assessed the change in a capability measure when a change
in health-related quality of life or mental health occurred.
The ICECAP-A is the first, simple measure of capability
well-being, potentially appropriate for use in trials testing
health interventions. Other indicators of capability are not
routinely used in health research. Therefore, quantifying
change in capability, against which the responsiveness of
the ICECAP-A measure could be assessed, was not pos-
sible. Other indicators of change must be used. From the
data available for this research, it was possible to quantify
change in both health-related quality of life and mental
health.
While the use of health as an anchor was motivated by
methodological considerations, when considering whether
a capability measure is suitable for use in a health research
setting researchers will likely want to know how it re-
sponds to changes in health, which in the vast majority of
situations is the primary outcome. This analysis of change
in a capability measure when a change in health occurs
may be equally or more useful to health researchers. Health
is one of many factors that affect a person’s capability
scores on the ICECAP-A measure. Smaller change in ca-
pability scores would therefore be expected in response to
changes in health.
Results
Participant characteristics
The characteristics of the BEEP trial participants used in
this responsiveness analysis are presented in Table 2. A
complete case analysis was completed, which included
those who completed the ICECAP-A measure at both
baseline and follow-up. The mean age of participants was
64, with a roughly equal proportion of male and female
participants. The average ICECAP-A capability tariff val-
ues were higher (indicating higher capability) at both
baseline and follow-up than values previously reported in
the general population [36]. Participants reported mean
EQ-5D-3L scores at baseline and follow-up, which were
lower than the UK national average for this age group,
indicating poorer health-related quality of life [37]. The
GAD-7 and PHQ-8 scores did not indicate high levels of
anxiety or depression within this sample [29, 30].
Table 2 shows that overall change in the ICECAP-A in
this population, between baseline and 6-month follow-up,
was negligible. This was also the case for other measures.
Mean change can ‘‘hide’’ individual change, and when
completing a responsiveness analysis, the range of change
which is present in a sample is an important consideration.
Analysis (see ‘‘Appendix 3’’) showed that the majority of
participants changed by less than 0.1 on the ICECAP-A
measure. Therefore, this responsiveness analysis was
completed in a population, which had high baseline ca-
pability and small changes between baseline and follow-
up.
Health-related quality of life: EQ-5D-3L anchor
Table 3 shows the change in non-weighted and value tariff
ICECAP-A scores in groups that reported improved and
worsened EQ-5D-3L scores. In groups that reported im-
proved EQ-5D-3L scores ICECAP-A scores increased; in
the groups that reported a worsening of EQ-5D-3L scores
ICECAP-A scores decreased. The change in ICECAP-A
scores was larger in the group that reported a worsening of
EQ-5D-3L than an improvement. ES and SRM for those
reporting an improvement in EQ-5D-3L were small for
both the non-weighted and the value tariff scores; for those
reporting a worsening in EQ-5D-3L scores, the ES and
SRM were moderate or approaching moderate. Change as a
percentage of possible change was smaller, in both the
improved and the worsened groups, for the value tariff
scores than for the non-weighted scores. The item-by-item
analysis (‘‘Appendix 4’’) shows that in the group reporting
improved EQ-5D-3L scores the largest changes were seen
in Stability, Autonomy and Achievement, while in the
group reporting a worsening the largest change was seen in
Autonomy and Enjoyment.
Table 1 Numbers and mean change in anchor measures used
Anchor Improved Worsened
Number
in group
Mean change
(95 % CI)
Change as %
of possible
change
Number
in group
Mean change
(95 % CI)
Change as %
of possible
change
EQ-5D-3L 97 0.29 (0.25, 0.33) 18.2 38 -0.31 (-0.37, -0.24) 19.3
GAD-7 83 4.843 (4.04, 5.64) 23.1 43 -4.93 (-6.08, -3.78) 23.5
PHQ-8 92 4.473 (5.14, 3.81) 18.6 54 -4.254 (-3.46, -5.05) 17.7
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Anxiety: GAD-7 anchor
Table 4 shows the change in non-value-weighted and value
tariff ICECAP-A scores in groups that reported improved
and worsened GAD-7 scores. In the group reporting an
improvement in GAD-7 scores the ICECAP-A scores
increased; in the group reporting a worsening of GAD-7
scores the scores decreased. The change in ICECAP-A
scores is larger in the group reporting a worsening of their
scores than in the group reporting an improvement of their
scores. ES and SRM for those reporting an improvement in
GAD-7 were small for both the non-weighted and the value
Table 2 BEEP trial sample characteristics, including mean scores and median scores
Attribute Measure
range
Sample
size
Mean baseline
values (SD)
Median value
baseline (IQR)
Mean follow-up
value (SD)
Median value
follow-up (IQR)
Age mean 357 63.9 (9.83)
Gender (% male) 357 49.3 %
ICECAP-A tariff 0–1 355 0.89 (0.11) 0.91 (0.85, 0.97) 0.89 (0.12) 0.92 (0.85, 0.97)
EQ-5D-3L index -0.59–1 351 0.64 (0.23) 0.69 (0.62, 0.76) 0.70 (0.22) 0.73 (0.69, 0.8)
GAD-7 0–21 344 3.14 (4.41) 1 (0, 4) 2.50 (3.91) 1 (0, 4)
PHQ-8 0–24 341 3.69 (4.44) 2 (1, 5) 2.99 (3.89) 2 (0, 4)
Table 3 Mean change in non-weighted ICECAP-A scores and ICECAP-A tariff scores by EQ-5D-3L index anchor change groups (n = 341)
Anchor group Baseline
ICECAP-A
Follow-up
ICECAP-A
Mean ICECAP-A
change (95 % CI)
Change as a %
of possible change
ES SRM
Non-weighted ICECAP-A scores
Improved 16.423 16.897 0.474** (0.123, 0.826) 3.2 0.20 0.27
No change 17.131 17.150 0.019 (-0.190, 0.229) 0.1 0.01 0.01
Worsened 16.895 15.842 -1.053** (-0.496, -1.609) 7.0 0.47 0.62
ICECAP-A tariff score
Improved 0.863 0.884 0.021* (0.001, 0.041) 2.1 0.17 0.21
No change 0.898 0.895 -0.003 (-0.128, 0.007) 0.3 0.02 0.03
Worsened 0.890 0.836 -0.054** (-0.084, -0.024) 5.4 0.53 0.59
* Significant at the 5 % level, ** significant at the 1 % level
Table 4 Mean change in non-weighted ICECAP-A scores and ICECAP-A tariff scores by GAD-7 anchor change groups (n = 335)
Anchor group Baseline
ICECAP-A
Follow-up
ICECAP-A
Mean ICECAP-A
change (95 % CI)
Change as a %
of possible change
ES SRM
Non-weighted ICECAP-A scores
Improved 16.012 16.390 0.378 (-0.024, 0.780) 2.5 0.15 0.21
No change 17.430 17.569 0.139 (-0.05, 0.328) 0.9 0.07 0.10
Worsened 16.442 15.279 -1.163** (-1.789, -0.537) 7.7 0.53 0.57
ICECAP-A tariff scores
Improved 0.844 0.864 0.020 (0.002 0.042) 2.0 0.14 0.20
No change 0.913 0.917 0.004 (-0.003, -0.011) 0.4 0.04 0.07
Worsened 0.863 0.792 -0.071** (-0.11, -0.032) 7.1 0.58 0.55
* Significant at the 5 % level, ** significant at the 1 % level
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tariff scores; for those reporting a worsening in GAD-7
scores, the ES and SRM were moderate or approaching
moderate. Change as a percentage of possible change was
smaller, in both the improved and the worsened groups, for
the value tariff scores than for the non-weighted scores.
The item-by-item analysis (‘‘Appendix 5’’) showed that in
those reporting improved GAD-7 scores the largest chan-
ges were seen in Stability and Enjoyment, while for those
reporting a worsening similar change were seen in all items
apart from Autonomy.
The use of the EQ-5D-3L as a comparison shows dif-
ferences from the ICECAP-A analysis (Table 5). The size
of the change as a percentage of possible change and the
SRM and ES were similar for both the weighted and the
non-weighted analyses; however, the directional pattern of
change was different. Change in the ICECAP-A was
greater for those reporting a worsening of anxiety (7.7 vs
2.5 % in the non-weighted scores). The reverse of this was
found in the EQ-5D-3L analysis (8.5 vs 2.2 % in the non-
weighted scores).
Depression: PHQ-8 anchor
In the group reporting an improvement in PHQ-8 scores
ICECAP-A scores increased, while in the group reporting a
worsening of PHQ-8 scores ICECAP-A scores decreased
(Table 6). The magnitude of change and the ES and SRM
were larger in the group who reported a worsening of an-
chor scores than in the group reporting an improvement.
Change as a percentage of possible change was smaller for
the value tariff than the non-weighted score. The item-by-
item analysis (‘‘Appendix 6’’) showed that in those re-
porting a worsening on PHQ-8 scores the largest change
was seen in Enjoyment, while in those reporting an
improvement the largest change was found in Stability and
Achievement.
The use of the EQ-5D-3L as a reference measure shows
differences from the ICECAP-A analysis (Table 7). The
size of the change as a percentage of possible change and
the SRM and ES were larger for the EQ-5D-3L analysis in
comparison with the ICECAP-A analysis. The directional
pattern of change was different. Change in the ICECAP-A
was greater for those reporting a worsening of anxiety
than for those reporting an improvement (5.8 vs 2.3 % in
non-weighted scores). The reverse of this was found in the
EQ-5D-3L analysis (2.2 vs 8.5 % in non-weighted
scores).
Discussion
This is the first analysis to assess the responsiveness of the
ICECAP-A measure using longitudinal data from a ran-
domised controlled trial. The results provide some positive
evidence for the responsiveness of the ICECAP-A mea-
sure. Small changes in the ICECAP-A scores were seen in
response to changes in health-related quality of life and
mental health status. In the GAD-7 (anxiety) and PHQ-8
(depression) analyses, ICECAP-A change was of a com-
parable size to change in the EQ-5D-3L reference measure,
but the pattern of change showed differences. Differences
were found between the value-weighted and non-value-
weighted ICECAP-A scores, with non-weighted scores
being slightly more responsive.
Discussion of principal findings
A number of important findings should be highlighted: (1)
a non-perfect relationship exists between health and
Table 5 Mean change in non-weighted EQ-5D-3L scores and EQ-5D-3L index scores by GAD-7 anchor change groups (n = 335) for
comparison
Anchor group Baseline
EQ-5D-3L scores
Follow-up
EQ-5D-3L scores
Mean EQ-5D-3L
change (95 % CI)
Change as a %
of possible change
ES SRM
Non-weighted EQ-5D-3L scores
Improved 8.16 7.308 -0.852** (-1.142, -0.561) 8.5 0.56 0.65
No change 7.421 7.015 -0.406** (-0.56, -0.253) 4.1 0.35 0.37
Worsened 7.878 8.097 0.219 (-0.69, 0.251) 2.2 0.14 0.14
EQ-5D-3L index scores
Improved 0.585 0.686 0.101** (0.052, 0.149) 6.3 0.39 0.46
No change 0.667 0.717 0.05** (0.022, 0.078) 3.1 0.24 0.24
Worsened 0.614 0.616 0.002 (-0.079, 0.083) 0.1 0.01 0.01
* Significant at the 5 % level, ** significant at the 1 % level
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capability scores, (2) differences exist between the non-
value-weighted and value-weighted ICECAP-A scores and
(3) the magnitude of change was similar for the ICECAP-A
and the EQ-5D-3L reference measure, with differences in
the patterns of change.
Results indicate a non-perfect relationship between
change in health and change in capability. In this con-
text, correlation between anchor change scores and
ICECAP-A change scores was weak, and change in
ICECAP value tariff was small in comparison with the
change in the anchors. A change in health represents a
change in one of a number of factors that affects a
person’s capability [10, 38]. Therefore, the impact that
small changes in health have upon change in the de-
scriptive system of the ICECAP-A measure may be
small. The results presented above provide supporting
evidence for this conclusion.
A comparison between the non-value-weighted ICE-
CAP-A scores and the value-weighted ICECAP-A tariff
change scores shows that change as a percentage of pos-
sible change is smaller for the value-weighted tariff scores
than for the non-value-weighted scores. This indicates that
when the value tariff was applied to the non-weighted
scores the magnitude of change was reduced. The value
tariff for the ICECAP-A was calculated using best–worst
scaling [10]. There are differences in the value attached to
change between the different within item levels. Significant
value is attached to change between the levels ‘‘none’’ and
‘‘a little’’, while little value is attached to changes between
‘‘a lot’’ and ‘‘all’’.
This responsiveness analysis was completed in a ‘‘high
capability’’ population (mean baseline ICECAP-A tariff
score was 0.89). The item-by-item analysis shows that the
majority of change in this population occurred among
respondents whose answers switched between the top two
levels of both measures. Therefore, the majority of
change occurred at the top of the measure. When apply-
ing the value tariff, these changes are of less value and
Table 6 Mean change in non-weighted ICECAP-A scores and ICECAP-A tariff scores by PHQ-8 anchor change groups (n = 331)
Anchor group Baseline
ICECAP-A
Follow-up
ICECAP-A
Mean ICECAP-A
change (95 % CI)
Change as %
of possible change
ES SRM
Non-weighted ICECAP-A scores
Improved 16.217 16.576 0.359 (-0.003, 0.720) 2.3 0.15 0.2
No change 17.486 17.616 0.13 (-0.077, 0.336) 0.8 0.07 0.09
Worsened 16.629 15.759 -0.87** (-1.398, -0.343) 5.8 0.37 0.45
ICECAP-A tariff scores
Improved 0.852 0.866 0.014 (-0.005, 0.032) 1.4 0.11 0.15
No change 0.917 0.92 0.003 (-0.006, 0.011) 0.3 0.02 0.03
Worsened 0.872 0.825 -0.048** (-0.078,-0.017) 4.8 0.39 0.43
* Significant at the 5 % level, ** significant at the 1 % level
Table 7 Mean change in EQ-5D-3L scores by PHQ-8 anchor change groups (n = 326) for comparison
Anchor group Baseline
EQ-5D-3L
Follow-up
EQ-5D-3L
Mean EQ-5D-3L
change (95 % CI)
Change as %
of possible change
ES SRM
Non-weighted EQ-5D-3L scores
Improved 8.161 7.309 -0.852** (-1.142,-0.561) 8.5 0.56 0.64
No change 7.421 7.015 -0.407** (-0.56,-0.253) 4.1 0.35 0.36
Worsened 7.878 8.097 0.219 (-0.251, 0.69) 2.2 0.14 0.15
EQ-5D-3L index scores
Improved 0.559 0.659 0.1** (0.05, 0.149) 6.3 0.37 0.42
No change 0.689 0.744 0.056** (0.029, 0.082) 3 0.33 0.31
Worsened 0.653 0.621 -0.031 (-0.098, 0.036) 2 0.13 0.13
* Significant at the 5 % level, ** significant at the 1 % level
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contribute less weight to the overall tariff score than
changes at the bottom of the measure. Consequently,
these changes at the top of the measure held less weight
in the value-weighted tariff score than they did in the
non-value-weighted score. These results show that the
responsiveness of the descriptive system is reduced when
the tariff is applied because changes at the ‘‘top end’’ are
not strongly valued.
The use of the EQ-5D-3L as a reference measure showed
that the size of change, the ESs and the SRMs were similar
for the non-weighted ICECAP-A scores as they were for the
non-weighted EQ-5D-3L scores. While the size of change
and the signal to noise ratios were similar, the pattern of
change was different. The ICECAP-A showed greater
change in groups whose mental health had deteriorated,
than improved. The opposite was found for EQ-5D-3L. This
may have been due to the high ICECAP-A score found at
baseline, leaving less scope for the scores on the measure to
change in response to an improvement in health.
Strengths and weaknesses of the research
There are a number of strengths of this research. The data
provided from the trial were well-completed, and the
availability of data from baseline and 6-month follow-up
allows longitudinal analysis of the ICECAP-A measure.
The anchor-based methodology used to assess the respon-
siveness of the measure represents best practice in the field.
There are some limitations that are worth noting. The use
of a trial population with high baseline capability and
showing small changes during the 6-month follow-up in
capability and health domains measured by anchors selected
results in some limitations in this analysis. The predominance
of health measures available for use as anchors, which would
likely be the case in most effectiveness trials of health in-
terventions, reduces the scope of the analysis by not allowing
assessment of how the measure responds to changes in other
determinants of capability. The absence of minimally im-
portant change values for the GAD-7 and PHQ-8 meant that
values used to define the groups were chosen based on se-
curing adequate numbers in each of the change groups. The
use of different values may have led to different results.
Implications of the work
The evidence of responsiveness presented in this paper
adds to the psychometric portfolio of the ICECAP-A
measure. These results should allow researchers to use the
ICECAP-A measure with greater confidence than has
previously been the case. Responsiveness is a context-
specific property, and therefore, caution should be exer-
cised in generalising these results.
The ICECAP measures have been highlighted by the
National Institute for Health and Care Excellence and the
Social Care Institute for Excellence as broad preference-
based measures, which are potentially suitable for use in
social care research [39]. This evidence provides an initial
indication that the ICECAP-A measure may be responsive
in healthcare research. This highlights the need for re-
sponsiveness evidence in other research areas, such as so-
cial care.
Directions for future research
Future research into the responsiveness of the ICECAP-A
measure would benefit from anchor measures assessing a
greater variation of constructs. The use of measures which
provide information on connectedness, happiness, inde-
pendence or hope, which are rarer in trials testing health-
care interventions, would add to our understanding of the
responsiveness of the ICECAP-A measure. A further area
for future research would be within populations which have
lower baseline capability than seen in this study and
populations who experience larger changes in capability
over time.
Conclusion
This paper provides the first evidence of responsiveness of
the ICECAP-A measure. Small changes in ICECAP-A
scores were seen in response to changes in physical and
psychological health. These results will be of interest to
both those looking to use the measure in research and those
currently assessing the psychometric properties of the
measure.
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Appendix 1: The ICECAP-A measure [10]3
3 This figure is published with the permission of the authors
of the paper.
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Appendix 2
An exploratory analysis of correlations between change scores of the outcome measures included in the BEEP trial.
Appendix 3
Frequency distribution of change in ICECAP-A tariff score.
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Appendix 4
The item-by-item analysis showed that in the group of
participants reporting a worsening of EQ-5D-3L index
scores there was a substantial reduction, of 21 points, in the
percentage of participants reporting full capability on the
Autonomy and Enjoyment items. In the group reporting an
improvement in EQ-5D-3L the largest increases were seen
in Stability, Autonomy and Achievement.
ICECAP-A score EQ-5D-3L index WOMAC pain WOMAC stiffness WOMAC function GAD-7 PHQ-8
ICECAP-A tariff 1.00
EQ-5D-3L score 0.255 1.00
WOMAC pain -0.055 -0.402 1.00
WOMAC stiffness -0.151 -0.236 0.507 1.00
WOMAC function -0.103 -0.380 0.737 0.592 1.00
GAD-7 -0.205 -0.202 0.109 0.040 0.129 1.00
PHQ-8 -0.190 -0.232 0.057 0.092 0.090 0.511 1.00
Highlighted in bold are the measures that were chosen as anchors for use in this analysis
ICECAP-A response profile for worsened EQ-5D-3L index scores
Baseline profile 6-month follow-up profile Change between baseline and follow-up
Stab Attach Auto Achieve Enjoy Stab Attach Auto Achieve Enjoy Stab Attach Auto Achieve Enjoy
Level 1 0 0 0 0 0 3 0 0 0 0 ?3 0 0 0 0
Level 2 10 5 3 13 8 18 13 5 18 18 ?8 ?8 ?2 ?5 ?10
Level 3 58 29 37 63 45 58 29 55 63 55 0 0 ?18 0 ?10
Level 4 32 66 60 24 47 21 58 39 18 26 -11 -8 -21 -6 -21
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ICECAP-A response profiles for improved EQ-5D-3L index scores
Baseline profile 6 month follow-up profile Change between baseline and follow-up
Stab Attach Auto Achieve Enjoy Stab Attach Auto Achieve Enjoy Stab Attach Auto Achieve Enjoy
Level 1 4 0 0 0 0 1 1 1 1 1 -1 ?1 ?1 ?1 ?1
Level 2 15 8 3 13 10 9 5 4 10 9 -6 -3 ?1 ?3 -1
Level 3 55 33 43 62 52 56 31 28 54 50 ?1 -2 -15 -8 -2
Level 4 26 59 54 25 38 34 63 67 35 39 ?8 ?4 ?13 ?10 ?1
ICECAP-A response profile for worsened GAD-7 health status
Baseline profile 6-month follow-up profile Change between baseline and follow-up
Stab Attach Auto Achieve Enjoy Stab Attach Auto Achieve Enjoy Stab Attach Auto Achieve Enjoy
Level 1 5 0 0 0 0 7 0 2 5 5 ?2 0 ?2 ?5 ?5
Level 2 11 9 7 12 12 30 21 7 16 16 ?19 ?12 0 ?4 ?4
Level 3 58 30 33 65 53 49 33 30 65 58 -9 ?3 -3 0 ?5
Level 4 26 60 60 23 35 14 46 60 14 21 -12 -14 0 -9 -14
ICECAP-A response profile for improved GAD-7 health status
Baseline profile 6-month follow-up profile Change between baseline and follow-up
Stab Attach Auto Achieve Enjoy Stab Attach Auto Achieve Enjoy Stab Attach Auto Achieve Enjoy
Level 1 4 0 0 0 0 0 1 0 0 1 -4 ?1 0 0 ?1
Level 2 19 11 5 17 16 18 8 2 12 12 -1 -3 -3 -5 -4
Level 3 59 32 38 65 60 55 32 36 69 57 -4 0 -2 ?4 -3
Level 4 18 57 57 18 24 27 58 61 19 30 ?9 ?1 ?4 ?1 ?6
ICECAP-A response profile for worsened PHQ-8 health status
Baseline profile 6-month follow-up profile Change between baseline and follow-up
Stab Attach Auto Achieve Enjoy Stab Attach Auto Achieve Enjoy Stab Attach Auto Achieve Enjoy
Level 1 2 0 0 0 0 4 2 0 2 4 ?2 ?2 0 ?2 ?4
Level 2 15 6 4 15 13 22 14 4 13 16 ?7 ?8 0 -2 ?3
Level 3 53 35 35 59 44 56 33 33 67 60 ?3 -2 -2 ?8 ?16
Level 4 30 59 61 26 43 18 51 64 18 20 -12 -8 ?3 -8 -23
Appendix 5
The item-by-item analysis showed that in the group of re-
spondents reporting a worsening of GAD-7 scores there was
a change of between 9 and 14 points in the percentage of
respondents answering full capability for all items expect
autonomy, which showed little change. In the group report-
ing an improvement in GAD-7 scores increase of 9 and 6
points were seen in the percentage of participants answering
full capability for Stability and Enjoyment items.
Appendix 6
The item-by-item analysis shows that in the group report-
ing a worsening of PHQ-8 health scores a substantial of 23
points is seen in the percentage of people reporting full
capability on the Enjoyment item. In the group reporting an
improvement in PHQ-8 health status increases of 7 and 14
percentage points were seen in the proportion of par-
ticipants reporting full capability on the Stability and
Achievement items, respectively.
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